Cardio Diagnostics Holdings, Inc.

CDIO

NASDAQ

Healthcare

Biotechnology

Chicago, IL, US13 employeescardiodiagnosticsinc.com

$2.04

-0.01(-0.25%)

Mkt Cap $4M

$1.05

$15.60

52-Week Range

At a Glance

AI-generated

Cardio Diagnostics Holdings, Inc.

Revenue breakdown: Reportable Segments (100%).

8-K

Cardio Diagnostics Holdings, Inc. filed an 8-K on February 19, 2026, disclosing an Investor Presentation as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' under Section 18 of the Exchange Act. This presentation provides investor-focused information.

$4M

Market Cap

$15.0K

Revenue

-$7M

Net Income

Employees13

Fundamentals

How The Business Makes Money

Revenue by Segment

Reportable Segments100%($99.4K)

Activity

What Changed Recently

Regulation FD

Feb 18, 2026

, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or oth

Peer Companies

Company	Price	Change	Market Cap	P/E
NRSNNeuroSense Therapeutics L...	$0.83	+9.22%	$20M	-2.2
BCLIBrainstorm Cell Therapeut...	$0.82	-2.37%	$9M	-0.9
IBOImpact BioMedical Inc.	$0.60	-1.55%	$8M	—
BCDABioCardia, Inc.	$1.19	+2.59%	$7M	-0.9
TCRTAlaunos Therapeutics, Inc...	$2.93	-0.68%	$7M	-1.7
RADXRadiopharm Theranostics L...	$4.38	+1.27%	$6M	—
CELZCreative Medical Technolo...	$2.05	+3.02%	$5M	-0.7
ADXNAddex Therapeutics Ltd	$5.72	-8.93%	$4M	-0.7

Analyst View

Company Profile

CIK0001870144

ISINUS14159C2026

CUSIP14159C202

Phone855 226 9991

Address400 N Aberdeen St, Chicago, IL, 60642, US

SEC EDGAR